About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...

For the quarter ended September 2024, Humana (HUM) reported revenue of $29.3 billion, up 14.8% over the same period last year. EPS came in at $4.16, compared to $7.78 in the year-ago quarter.The reported revenue represents a surprise of +2.24% over the Zacks Consensus Estimate of $28.66 billion. With the consensus EPS estimate being $3.48, the EPS surprise was +19.54%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their ...

Humana (HUM) came out with quarterly earnings of $4.16 per share, beating the Zacks Consensus Estimate of $3.48 per share. This compares to earnings of $7.78 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 19.54%. A quarter ago, it was expected that this health insurer would post earnings of $5.89 per share when it actually produced earnings of $6.96, delivering a surprise of 18.17%. Over the last four quarters, the company ha ...

n e w s r e l e a s e Exhibit 99.2 Humana Inc. 500 West Main Street P.O. Box 1438 Louisville, KY 40202 http://www.humana.com FOR MORE INFORMATION CONTACT: Lisa Stoner Humana Investor Relations (502) 580-2652 e-mail: LStamper@humana.com Mark Taylor Humana Corporate Communications (317) 753-0345 e-mail: MTaylor108@humana.com Humana Reports Third Quarter 2024 Financial Results; Updates Full Year Adjusted 2024 Financial Guidance • Reports 3Q24 earnings per share (EPS) of $3.98 on a GAAP basis, Adjusted EPS of $ ...

Humana Inc. (HUM) is slated to release third-quarter 2024 results on Oct. 30, before the opening bell. The Zacks Consensus Estimate for earnings per share is pegged at $3.48, which indicates a 55.3% plunge from the prior-year quarter's number. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The third-quarter earnings estimate has witnessed two downward revisions over the past month. During this time, the estimate declined 1.7%. Meanwhile, the Zacks Consensus Estimate for revenues i ...

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Humana Inc. (“Humana” or the “Company”) (NYSE: HUM) on behalf of Humana stockholders. Our investigation concerns whether Humana has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On October 2, 2024, Humana disclosed that it has “approximately 1.6 million, or 2 ...

Shares of Humana Inc (NYSE:HUM) and Cigna Group (NYSE:CI) are making opposite moves today, as merger talks between the health insurance companies ramp up. According to a Bloomberg report that cited people familiar with the matter, the talks are in early stages.At last glance, HUM is 0.5% higher at $268.55. The equity is still down nearly 50% in the past 12 months, with a more than 40% year-to-date deficit to boot. Humana stock could today conquer its 20-day moving average, as it distances itself from its Oc ...

公司动态 - Humana股价在周一盘前交易中大幅上涨，原因是Cigna重新启动了与这家陷入困境的健康保险公司的合并谈判 [1][2] - 据知情人士透露，两家公司已就潜在交易进行了非正式初步讨论，但尚未达成任何协议或时间表 [1] - 去年12月，Cigna和Humana因未能就价格达成一致而放弃了潜在的收购 [1] 股价表现 - Humana股价自年初以来已下跌超过40%，主要由于医疗保险计划注册人数大幅下降、医疗需求增加导致成本上升以及政府报销减少 [2] - 周一开盘前半小时，Humana股价上涨约4%，至278美元左右 [2] - 自去年7月初回撤至200周移动平均线以来，Humana股价一直在下降通道内交易 [3] - 上个月股价跌破该通道，但随后迅速回升至通道下轨，可能表明存在熊市陷阱 [3] - 9月的下跌发生在自2009年2月以来的最高周成交量上，可能预示着投降性抛售 [3] 技术分析 - 投资者应关注Humana股价的关键阻力位，包括300美元、370美元和450美元 [1][4] - 300美元附近可能遇到阻力，370美元附近可能遇到下降通道上轨和50周移动平均线的阻力，450美元附近可能遇到200周移动平均线的阻力 [4] - 如果股价下跌，投资者应密切关注230美元的关键支撑位，该水平在2019年4月至今年9月期间曾三次得到买盘支撑 [4]

NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. ("Humana" or "the Company") (NYSE: HUM). Investors who purchased Humana securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HUM. Investigation Details On October 2, 2024, Humana disclosed that it has "approximately 1.6 million, or 25%, of its members currently ...

文章核心观点 - 美国医疗保险公司Humana的Medicare评级下降,导致其股价大跌 [1] - Humana正在就评级过程提出上诉,称评级过程存在缺陷 [1] - Humana的股价今年已大幅下跌,主要受到医疗成本上升和政府监管影响 [1] 公司概况 - Humana是一家大型医疗保险公司,主要经营Medicare Advantage计划 [1] - Humana的一个Medicare Advantage计划的评级从4.5星下降到3.5星,这会影响其获得的奖励性付款 [1] 行业动态 - 同行United Health Group和Elevance Health去年就评级问题提出上诉并获得成功 [1] - 医疗保险公司普遍面临医疗成本上升和政府监管加强的挑战 [1]